顺铂治疗后的溶血性贫血。
Haemolytic anaemia after cisplatin treatment.
作者信息
Levi J A, Aroney R S, Dalley D N
出版信息
Br Med J (Clin Res Ed). 1981 Jun 20;282(6281):2003-4. doi: 10.1136/bmj.282.6281.2003.
Abstract
Normochromic or normocytic anaemia is a common side effect of treatment with cisplatin. Two patients treated with cisplatin 100 mg/m2 in combination with vinblastine, bleomycin, and actinomycin D developed haemolytic anaemia. Neither patient had evidence of haemolysis before treatment, and in both cases severe haemolytic anaemia developed after several courses of cisplatin and when the cancer had regressed almost completely. The importance of haemolysis in the development of anaemia after cisplatin treatment has not been investigated fully and further studies are needed.
摘要
正色素性或正细胞性贫血是顺铂治疗常见的副作用。两名接受100mg/m²顺铂联合长春碱、博来霉素和放线菌素D治疗的患者发生了溶血性贫血。两名患者在治疗前均无溶血证据，且在两个病例中，严重溶血性贫血均在顺铂治疗几个疗程后且癌症几乎完全消退时发生。顺铂治疗后溶血在贫血发生中的重要性尚未得到充分研究，需要进一步研究。
相似文献
1
Haemolytic anaemia after cisplatin treatment.顺铂治疗后的溶血性贫血。
Br Med J (Clin Res Ed). 1981 Jun 20;282(6281):2003-4. doi: 10.1136/bmj.282.6281.2003.
2
Cisplatin-induced hemolysis.顺铂诱导的溶血。
N Engl J Med. 1980 Feb 7;302(6):334-5. doi: 10.1056/NEJM198002073020607.
3
Long-term treatment with cis-dichlorodiammineplatinum(II)-vinblastine-bleomycin: possible association with severe coronary artery disease.
Cancer Treat Rep. 1979 Apr;63(4):551-2.
4
Hemorrhagic cystitis after i.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancer.
Cancer Treat Rep. 1986 Apr;70(4):548-9.
5
Early-onset thrombocytopenia in the chemotherapy of testicular teratoma.睾丸畸胎瘤化疗中的早发性血小板减少症。
Eur J Cancer Clin Oncol. 1983 Jun;19(6):867. doi: 10.1016/0277-5379(83)90022-6.
6
Longitudinal studies of nutritional status in patients having chemotherapy for testicular teratomas.对接受睾丸畸胎瘤化疗患者营养状况的纵向研究。
Clin Oncol. 1983 Mar;9(1):3-10.
7
Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.顺铂、长春碱和博来霉素（PVB）化疗后发生的第二原发性恶性肿瘤：一例报告。
Cancer Treat Rep. 1983 Apr;67(4):410.
8
Advanced male non-seminomatous germ-cell tumours. Combination chemotherapy with cis-platinum, vinblastine and bleomycin.
Med J Aust. 1979 Dec 15;2(12):630-2.
9
Combination chemotherapy with cis-dichlorodiammineplatinum(II) and adriamycin for testicular cancer refractory to vinblastine plus bleomycin.
Cancer Treat Rep. 1978 Sep;62(9):1351-3.
10
Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin.
J Clin Oncol. 1983 Jun;1(6):392-3. doi: 10.1200/JCO.1983.1.6.392.
引用本文的文献
1
Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway.二氢丹参酮I通过Wnt/β-连环蛋白信号通路抑制骨肉瘤的生长。
Onco Targets Ther. 2019 Jul 2;12:5111-5122. doi: 10.2147/OTT.S204574. eCollection 2019.
2
In vitro cytotoxicity activity of novel Schiff base ligand-lanthanide complexes.新型希夫碱配体-镧系配合物的体外细胞毒性活性。
Sci Rep. 2018 Feb 14;8(1):3054. doi: 10.1038/s41598-018-21366-1.
3
Carboplatin Induced Fatal Autoimmune Hemolytic Anemia: First Reported Case.卡铂诱发致命性自身免疫性溶血性贫血：首例报告病例
World J Oncol. 2010 Aug;1(4):173-175. doi: 10.4021/wjon234w. Epub 2010 Aug 29.
4
Bactericidal activity of alpha-bromocinnamaldehyde against persisters in Escherichia coli.α-溴肉桂醛对大肠杆菌中持留菌的杀菌活性。
PLoS One. 2017 Jul 27;12(7):e0182122. doi: 10.1371/journal.pone.0182122. eCollection 2017.
5
Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway.杨梅素通过p53依赖的凋亡途径抑制顺铂耐药癌细胞的增殖。
Int J Oncol. 2015 Oct;47(4):1494-502. doi: 10.3892/ijo.2015.3133. Epub 2015 Aug 25.
6
Nonpreventive Role of Aerobic Exercise Against Cisplatin-induced Nephrotoxicity in Female Rats.有氧运动对顺铂诱导的雌性大鼠肾毒性的非预防作用。
Int J Prev Med. 2015 Jul 8;6:58. doi: 10.4103/2008-7802.160333. eCollection 2015.
7
Benzene-poly-carboxylic acid complex, a novel anti-cancer agent induces apoptosis in human breast cancer cells.苯多羧酸复合物，一种新型抗癌剂，可诱导人乳腺癌细胞凋亡。
PLoS One. 2014 Feb 11;9(2):e85156. doi: 10.1371/journal.pone.0085156. eCollection 2014.
8
Hypersensitivity and cross-reactivity to cisplatin and analogues.
Cancer Chemother Pharmacol. 1995;35(4):349-51. doi: 10.1007/BF00689458.
9
Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.顺铂在裸鼠体内的药代动力学和组织分布：铂含量和顺铂-DNA加合物
Cancer Chemother Pharmacol. 1995;37(1-2):23-31. doi: 10.1007/BF00685625.
10
Effects of cisplatin on different haemopoietic progenitor cells in mice.顺铂对小鼠不同造血祖细胞的影响。
Br J Cancer. 1982 Sep;46(3):397-402. doi: 10.1038/bjc.1982.216.
本文引用的文献
1
Cisplatin toxicity for erythroid precursors.顺铂对红系前体细胞的毒性作用。
N Engl J Med. 1981 Feb 5;304(6):360. doi: 10.1056/NEJM198102053040617.
2
Cisplatin-induced hemolysis.顺铂诱导的溶血。
N Engl J Med. 1980 Feb 7;302(6):334-5. doi: 10.1056/NEJM198002073020607.
3
Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.给动物肠胃外注射顺式二氯二氨铂（II）后铂的处置与分布。
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1485-92.
4
Toxic effects of cis-dichlorodiammineplatinum(II) in man.顺二氯二氨合铂（II）对人体的毒性作用。
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1527-31.
5
Cis-platinum: a new anticancer agent.顺铂：一种新型抗癌药。
Br Med J. 1979 Jun 23;1(6179):1689-91. doi: 10.1136/bmj.1.6179.1689.
Zotero 插件